Tabatabai G - Search Results

1

MRI and ¹⁸FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial.

Wirsching HG, Roelcke U, Weller J, Hundsberger T, Hottinger AF, von Moos R, Caparrotti F, Conen K, Remonda L, Roth P, Ochsenbein A, Tabatabai G, Weller M. Wirsching HG, et al. Among authors: tabatabai g. Clin Cancer Res. 2021 Jan 1;27(1):179-188. doi: 10.1158/1078-0432.CCR-20-2096. Epub 2020 Sep 23. Clin Cancer Res. 2021. PMID: 32967939 Free article. Clinical Trial.

2

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

Tabatabai G, Frank B, Möhle R, Weller M, Wick W. Tabatabai G, et al. Brain. 2006 Sep;129(Pt 9):2426-35. doi: 10.1093/brain/awl173. Epub 2006 Jul 10. Brain. 2006. PMID: 16835250

3

Synergistic antiglioma activity of radiotherapy and enzastaurin.

Tabatabai G, Frank B, Wick A, Lemke D, von Kürthy G, Obermüller U, Heckl S, Christ G, Weller M, Wick W. Tabatabai G, et al. Ann Neurol. 2007 Feb;61(2):153-61. doi: 10.1002/ana.21057. Ann Neurol. 2007. PMID: 17212356

4

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro.

Maurer GD, Tritschler I, Adams B, Tabatabai G, Wick W, Stupp R, Weller M. Maurer GD, et al. Among authors: tabatabai g. Neuro Oncol. 2009 Dec;11(6):747-56. doi: 10.1215/15228517-2009-012. Neuro Oncol. 2009. PMID: 19221171 Free PMC article.

5

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.

Miller J, Eisele G, Tabatabai G, Aulwurm S, von Kürthy G, Stitz L, Roth P, Weller M. Miller J, et al. Among authors: tabatabai g. J Neurosurg. 2010 Aug;113(2):280-5. doi: 10.3171/2009.11.JNS09901. J Neurosurg. 2010. PMID: 19961309

6

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

Tabatabai G, Hasenbach K, Herrmann C, Maurer G, Möhle R, Marini P, Grez M, Wick W, Weller M. Tabatabai G, et al. Int J Oncol. 2010 Jun;36(6):1409-17. doi: 10.3892/ijo_00000626. Int J Oncol. 2010. PMID: 20428764

7

GDF-15 contributes to proliferation and immune escape of malignant gliomas.

Roth P, Junker M, Tritschler I, Mittelbronn M, Dombrowski Y, Breit SN, Tabatabai G, Wick W, Weller M, Wischhusen J. Roth P, et al. Among authors: tabatabai g. Clin Cancer Res. 2010 Aug 1;16(15):3851-9. doi: 10.1158/1078-0432.CCR-10-0705. Epub 2010 Jun 9. Clin Cancer Res. 2010. PMID: 20534737 Free article.

8

Targeting integrins in malignant glioma.

Tabatabai G, Weller M, Nabors B, Picard M, Reardon D, Mikkelsen T, Ruegg C, Stupp R. Tabatabai G, et al. Target Oncol. 2010 Sep;5(3):175-81. doi: 10.1007/s11523-010-0156-3. Epub 2010 Sep 4. Target Oncol. 2010. PMID: 20820929 Review.

9

Molecular diagnostics of gliomas: the clinical perspective.

Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M. Tabatabai G, et al. Acta Neuropathol. 2010 Nov;120(5):585-92. doi: 10.1007/s00401-010-0750-6. Epub 2010 Sep 23. Acta Neuropathol. 2010. PMID: 20862485 Review.

10

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

Weller M, Wick W, Hegi ME, Stupp R, Tabatabai G. Weller M, et al. Among authors: tabatabai g. Future Oncol. 2010 Sep;6(9):1407-14. doi: 10.2217/fon.10.113. Future Oncol. 2010. PMID: 20919826 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters